Arkolith/Insider Trading/ADXS/Form 4

Israel Biotech Fund GP Partners II, L.P.

10% OwnerAyala Pharmaceuticals, Inc. (ADXS) · full profile →Form 4 · filed Oct 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 18, 2023Buy(P)659K—$01.1M
Oct 18, 2023Buy(P)659K—$02.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-23-003462) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML